Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Sales of Eylea, which the company co-developed with Bayer (DE:BAYA), rose 2% to $1.495 billion. Sales of the higher-dose, longer-lasting formulation Eylea HD rose 148% to $305 million in the U.S., ...

Moments after Regeneron CEO Len Schleifer scolded analysts for asking too many questions about the disappointing sales of eye ...

Researchers Shed Light on How to Predict Which Skin Cancer Patients Are Most Likely to Respond to Immunotherapy Jan. 8, 2025 — An international team of UK and US scientists discovered that the ...

Piper Sandler adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN) shares, reducing it from the previous $1,195.00 to $1,013.00. Despite this change, the firm maintained its ...

Read more here. Building a skin-care routine for teens and tweens can seem complicated. Puberty is often the first time kids are dealing with acne, blackheads, dry patches, and the general roller ...

as well as to rule out primary cutaneous squamous cell carcinoma or metastasis from second squamous cell carcinoma from other sites. Our case also underscores the importance of performing a prompt ...

Libtayo was approved in 2018 for advanced cutaneous squamous cell carcinoma, and since then has also been cleared for basal cell carcinoma and most recently first-line non-small cell lung cancer ...

In this report, we present the largest case series of patients developing AK and/or cutaneous SCC during therapy with sorafenib. The mechanism through which sorafenib may be implicated in the ...

It's officially that time of the year: our skin is itchy, scaly, and more closely resembles a lizard than a dewy, glazed donut. You likely have a dozen barrier-repairing lip balms and thick hand ...